Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I)

Bioorg Med Chem. 2009 Apr 15;17(8):3053-60. doi: 10.1016/j.bmc.2009.02.063. Epub 2009 Mar 6.

Abstract

Overexpression of zinc-dependent metalloproteinase, aminopeptidase N (APN/CD13), is considered to be involved in the process of tumor invasion and metastasis. Herein we describe the synthesis and in vitro enzymatic inhibition assay of antineoplaston AS2-5 scaffold peptidomimetic compounds. The results demonstrated that most of these L-iso-glutamine derivatives displayed selective inhibitory activity against APN as compared with MMP-2, with IC(50) values in the micromole range. The structure-activity relationships were also briefly discussed.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • CD13 Antigens / antagonists & inhibitors*
  • CD13 Antigens / chemistry
  • Glutamine / analogs & derivatives*
  • Glutamine / chemistry
  • Glutamine / pharmacology
  • Inhibitory Concentration 50
  • Kinetics
  • Models, Molecular
  • Phenylacetates / chemistry
  • Phenylacetates / pharmacology*
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Phenylacetates
  • Protease Inhibitors
  • Glutamine
  • CD13 Antigens